Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05755568

A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain

Conditions: Metachromatic Leukodystrophy (MLD)

Sex: All

Ages: 0 Years – 15 Years

Enrollment: 30

Sponsor: Takeda

Location: Spain

Summary

The main aim of this study is to learn about metachromatic leukodystrophy (MLD) in children and teenagers in Spain. This includes checking the number of new MLD cases and the frequency of children with MLD in 2022 in Spain.There is no treatment involved in this study. Participants' data will be taken from their medical records (charts), which were already collected as a part of their routine care between 01 January 2000 and 31 December 2022.

Eligibility Criteria

Inclusion Criteria:• Diagnosed with late infantile or juvenile MLD at any time between 01 January 2000 and 31 December 2022 (genetically and/or biochemically confirmed).Exclusion Criteria:• This study has no exclusion criteria.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05755568). StuddyBuddy aggregates publicly available trial information.